Cargando…
The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma is a frequent and poor prognosis tumor, with most patients facing up, soon or later, to systemic therapies. So far, systemic therapies based on tyrosine kinase inhibitor monotherapies have been of modest benefit. The aim of this review article was to characte...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826922/ https://www.ncbi.nlm.nih.gov/pubmed/33440630 http://dx.doi.org/10.3390/cancers13020238 |